sever
acut
respiratori
syndrom
sar
emerg
late
southern
china
rapidli
spread
countri
around
globe
three
research
group
within
world
health
organ
coordin
network
independ
simultan
shown
novel
coronaviru
link
sar
fourth
group
complet
koch
postul
infect
monkey
agent
sequenc
complet
genom
achiev
week
first
isol
viru
becam
avail
sever
acut
respiratori
syndrom
sar
first
report
new
diseas
entiti
world
health
organ
carlo
urbani
work
hanoi
vietnam
februari
succumb
sar
march
retrospect
report
china
case
compat
diseas
date
back
novemb
diseas
involv
initi
febril
phase
follow
interstiti
pneumonia
lead
respiratori
distress
syndrom
death
fraction
patient
cumul
case
fatal
rate
time
write
basi
gammadistribut
model
number
recent
correct
valu
patient
year
age
becam
clear
midmarch
hospit
outbreak
high
rate
transmiss
simultan
occur
hanoi
singapor
hong
kong
toronto
canada
issu
global
health
alert
initi
studi
network
laboratori
dedic
clarifi
etiolog
sar
four
recent
articl
describ
member
network
rapidli
identifi
confirm
novel
coronaviru
caus
agent
independ
yet
collabor
manner
begin
investig
known
caus
agent
interstiti
pneumonia
sought
patient
differ
site
outbreak
anecdot
result
laboratori
point
involv
chlamydia
rhinovirus
paramyxovirus
howev
laboratori
could
confirm
presenc
pathogen
cohort
patient
initi
experiment
step
three
group
later
succeed
identifi
caus
pathogen
inocul
variou
cell
cultur
line
patient
specimen
wherea
cell
commonli
use
respiratori
pathogen
eg
rde
hela
mdck
yield
indic
result
viru
could
replic
monkey
kidney
cell
group
hong
kong
first
observ
cytopath
effect
compat
viral
growth
day
inocul
lung
biopsi
specimen
nasopharyng
aspir
sampl
fetal
rhesu
kidney
cell
cytopath
effect
consist
cell
round
detach
specif
immun
respons
infect
cell
observ
patient
typic
sar
healthi
blood
donor
similar
find
confirm
two
group
use
african
green
monkey
kidney
vero
cell
two
group
proceed
analysi
cell
cultur
supernat
electron
microscopi
center
diseas
control
prevent
cdc
atlanta
team
first
observ
typic
electron
microscopi
morpholog
coronavirus
exemplifi
fig
basi
conserv
amino
acid
region
polymeras
gene
known
coronavirus
group
design
primer
direct
polymeras
gene
coronavirus
amplifi
bp
fragment
new
agent
fragment
sequenc
compar
genbank
time
group
europ
hong
kong
amplifi
viru
cell
cultur
supernat
random
revers
transcriptas
polymeras
chain
reaction
rtpcr
techniqu
one
group
appli
differenti
display
primer
clone
obtain
rtpcr
fragment
subsequ
sequenc
group
util
degener
primer
produc
random
rtpcr
product
lowstring
condit
direct
sequenc
group
first
report
network
phylogenet
analysi
one
two
polymeras
gene
fragment
found
alreadi
suggest
novel
agent
constitut
independ
genet
group
within
genu
coronaviru
genom
fragment
obtain
europ
america
exchang
network
shown
amplif
sequenc
continu
stretch
cdna
fragment
physic
locat
one
viral
genom
analyz
sequenc
bridg
commun
fragment
length
product
obtain
kb
concord
would
expect
coronaviru
genom
sequenc
obtain
american
isol
found
ident
base
european
isol
european
isol
deriv
singapor
american
one
hanoi
thu
proven
viru
present
two
geograph
separ
outbreak
diseas
link
agent
diseas
identif
coronaviru
cultur
specimen
singl
patient
three
group
devis
specif
rtpcr
primer
base
sequenc
inform
gather
could
demonstr
presenc
viru
larg
fraction
sar
patient
cohort
well
absenc
control
group
primer
sequenc
exchang
network
group
confirm
presenc
viru
patient
immunofluoresc
test
show
specif
immun
respons
sar
patient
healthi
control
total
patient
respiratori
diseas
koch
postul
final
fulfil
infect
cynomolgu
macaqu
macaca
fasciculari
isol
coronaviru
hong
kong
provid
proof
experiment
infect
newli
discov
coronaviru
etiolog
agent
diseas
typic
symptom
patholog
find
observ
human
present
monkey
symptom
found
monkey
infect
human
metapneumoviru
anoth
prime
suspect
time
addit
observ
fraction
sar
patient
superinfect
human
metapneumoviru
aggrav
symptom
final
specif
immun
respons
new
viru
could
detect
agent
could
reisol
anim
wealth
data
hand
four
week
first
cytopath
effect
observ
cell
line
invit
laboratori
particip
sar
etiolog
network
geneva
april
identif
etiolog
agent
sar
formal
announc
viru
provision
term
sarscoronaviru
sarscov
implic
genom
soon
first
isol
sarscov
becam
avail
genom
sequenc
initi
five
differ
group
complet
almost
simultan
group
atlanta
rotterdam
commun
larg
fragment
preliminari
sequenc
data
ongo
project
greatli
acceler
progress
team
group
canada
publish
internet
first
complet
genom
viru
synopsi
articl
relat
sarscov
sequenc
yield
sever
interest
implic
phylogenet
analysi
import
gene
sarscov
show
constitut
fourth
novel
monophylet
group
within
genu
coronaviru
evid
recombin
coronavirus
suggest
agent
evolv
independ
longer
period
time
reason
evolut
occur
anim
reservoir
rather
human
preliminari
data
suggest
human
popul
lack
antibodi
sarscov
genom
sarscov
hemagglutinin
esteras
gene
gene
present
group
coronavirus
common
ancestor
thought
acquir
horizont
influenza
c
viru
like
group
coronavirus
spike
protein
sarscov
mani
group
coronavirus
cleav
two
domain
lack
typic
cleavag
recognit
site
common
group
coronavirus
sarscov
one
instead
two
papainlik
proteas
encod
open
read
frame
similar
avian
infecti
bronchiti
viru
group
untransl
region
sarscov
contain
conserv
sequenc
motif
thought
acquir
horizont
astrovirus
two
distinct
genotyp
sarscov
identifi
compar
complet
genom
sequenc
isol
differ
site
outbreak
one
genotyp
repres
isol
deriv
one
point
sourc
transmiss
patient
stay
one
particular
hotel
hong
kong
differ
clinic
pictur
associ
genotyp
nonconserv
amino
acid
exchang
domain
spike
protein
might
first
hint
sarscov
respond
immunoselect
pressur
etiolog
sar
identifi
unpreced
rapid
facilit
unconvent
approach
inform
exchang
technic
path
success
rather
convent
one
agent
could
cultur
combin
classic
method
cell
cultur
electron
microscopi
immunofluoresc
basic
molecular
biolog
techniqu
rtpcr
random
prime
suffici
identif
set
noncultur
agent
found
either
moresophist
molecular
techniqu
like
subtract
amplif
repres
differ
analysi
morecomplex
combin
classic
molecular
method
necessari
pathogen
genom
hand
necessari
step
diagnos
treat
studi
pathogenesi
diseas
undertaken
lesson
learn
identif
sarscov
gener
rather
scientif
one
situat
impend
epidem
scientist
abl
cooper
high
level
profici
effici
manner
common
trait
scientist
competit
direct
product
direct
clever
guidanc
demonstr
communic
diseas
surveil
respons
team
